Issues we address

  • Viral diseases
    (e.g., HIV, HPV, EBV, Dengue, Japanese Encephalitis, West Nile Virus, Ross River fever, Chikungunya)
     
  • Parasite diseases 
    (e.g., Malaria, Hydatid disease, Leishmaniasis, Schistosomiasis)
     
  • Vector-borne diseases and interaction of infectious disease agents with vectors
     
  • Emergence of microbial infections
    (e.g., HIV, H1N1, H5N1, SARS, Epidemic meningococcal diseases, Group A streptococci serotype M1T1) 
  • Development of antimicrobial resistance
    (e.g., extensively drug resistant Mycobacterium tuberculosis [XDR-TB], methicillin resistant Staphylococcus aureus [MRSA], extended spectrum β-lactamase resistant Gram negative-pathogens, XDR-Acinetobacter, vancomycin-resistant enterococci, Psudomonas aeruginosa etc)
     
  • The polymicrobial nature of infectious diseases whereby, for instance, viruses facilitate bacterial infections
     
  • Host-pathogen communication and signalling